Lipitor Gains New Indications For Patients With Established Heart Disease
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approves Pfizer’s atorvastatin for five new indications based on the results of the Treating to New Targets trial.
You may also be interested in...
Lipitor Sales Plummet 13 Percent In Q2 On Inventory Fluctuations, Generic Pressure
Pfizer also reports 48 percent drop in earnings due to patent losses, upfront payment to Bristol for anticoagulant apixaban deal.
Lipitor Sales Plummet 13 Percent In Q2 On Inventory Fluctuations, Generic Pressure
Pfizer also reports 48 percent drop in earnings due to patent losses, upfront payment to Bristol for anticoagulant apixaban deal.
New Lipitor Ads Will Feature Recently Cleared Heart Disease Claims
Campaign for the statin will run in print and on TV.